Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_provenance.
- NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_assertion description "[Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_provenance.
- NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_assertion evidence source_evidence_literature NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_provenance.
- NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_assertion SIO_000772 16651424 NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_provenance.
- NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_assertion wasDerivedFrom befree-2016 NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_provenance.
- NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_assertion wasGeneratedBy ECO_0000203 NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_provenance.
- befree-2016 importedOn "2016-02-19" NP547733.RAVuWhzIGwhqb0eoyd5EroTjGwx3iIp3S-2LTpkyykuSs130_provenance.